Ma Yun-Bin, Wang Zhi-Jie
The First Surgical Department, Hebei Medical University Yiling Hospital, Shijiazhuang 050000, Hebei Province, China.
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing 100142, China.
World J Clin Oncol. 2025 Aug 24;16(8):108906. doi: 10.5306/wjco.v16.i8.108906.
Compared with colorectal adenocarcinoma, neuroendocrine neoplasms (NENs), which affect the colon and rectum, are uncommon tumor conditions that have received relatively limited attention in basic research. Furthermore, the scarcity of these NENs has hindered extensive clinical investigations, thereby leading to a dearth of robust evidence for guiding clinical practice and impeding the establishment of standardized approaches for diagnosis and treatment. However, with the increasing awareness of population screening, as well as the increasing popularity of colonoscopy screening programs, the incidence of colorectal NENs has gradually increased. Moreover, some high-grade NENs are highly malignant and invasive, thereby leading to poor treatment outcomes and prognoses. These challenges have elicited increased attention from clinical physicians, thus prompting researchers to explore relevant studies using limited specimens and clinical data. This scenario has resulted in preliminary findings that provide evidence for addressing diagnostic and therapeutic challenges associated with NENs of the colon and rectum. In this article, we review recent literature reports and summarize the advances regarding the diagnosis and treatment of colorectal NENs.
与结肠直肠癌相比,影响结肠和直肠的神经内分泌肿瘤(NENs)是罕见的肿瘤疾病,在基础研究中受到的关注相对有限。此外,这些神经内分泌肿瘤数量稀少,阻碍了广泛的临床研究,从而导致缺乏有力证据来指导临床实践,并阻碍了标准化诊断和治疗方法的建立。然而,随着人群筛查意识的提高以及结肠镜筛查项目的日益普及,结直肠神经内分泌肿瘤的发病率逐渐上升。此外,一些高级别神经内分泌肿瘤具有高度恶性和侵袭性,从而导致治疗效果和预后较差。这些挑战引起了临床医生的更多关注,促使研究人员利用有限的标本和临床数据探索相关研究。这一情况已产生初步结果,为应对与结肠和直肠神经内分泌肿瘤相关的诊断和治疗挑战提供了证据。在本文中,我们回顾了近期的文献报道,并总结了结直肠神经内分泌肿瘤诊断和治疗方面的进展。